Department of Vascular Surgery, Solihull Hospital, Heart of England NHS Foundation Trust, Birmingham, United Kingdom.
J Vasc Surg. 2013 Jan;57(1):103-7. doi: 10.1016/j.jvs.2012.07.024. Epub 2012 Nov 7.
Abdominal aortic aneurysm (AAA) is associated with a prothrombotic diathesis that may increase the risk of cardiovascular events. This diathesis is exacerbated in the short term by open aneurysm repair (OAR) and endovascular aneurysm repair (EVAR). However, the effect of EVAR and OAR on coagulation and fibrinolysis in the medium and long term is poorly understood. The purpose of this study was to investigate the medium-term effects of EVAR and OAR on thrombin generation, neutralization, and fibrinolysis.
Prothrombin fragment (PF)1+2, thrombin antithrombin (TAT) complex, plasminogen activator inhibitor (PAI) activity, and tissue-plasminogen activator (t-PA) antigen were measured in eight age-matched controls (AMCs), 29 patients with AAA immediately before (preoperatively) and 12 months after EVAR (post-EVAR), and in 11 patients at a mean of 16 months after OAR (post-OAR).
Preoperatively, PF1+2 levels were significantly higher in patients with AAAs than in AMC. PF1+2 levels post-EVAR and post-OAR were significantly lower than preoperative values and similar to AMC. There was no significant difference in TAT, PAI, or t-PA between AMC, AAA preoperatively, and post-EVAR. Post-OAR, PAI activity was significantly higher than in preoperative patients.
AAA is associated with increased thrombin generation without upregulation of fibrinolysis. The prothrombotic, hypofibrinolytic diathesis observed in patients with AAA returns toward normal in the medium term after EVAR and OAR, although there is a trend toward decreased fibrinolysis post-OAR.
腹主动脉瘤(AAA)与促血栓形成状态相关,这可能会增加心血管事件的风险。这种状态在开放型动脉瘤修复术(OAR)和血管内动脉瘤修复术(EVAR)后短期内会加重。然而,EVAR 和 OAR 对凝血和纤溶的中长期影响知之甚少。本研究旨在探讨 EVAR 和 OAR 对凝血酶生成、中和和纤溶的中期影响。
在 8 名年龄匹配的对照组(AMC)、29 名 AAA 患者手术前(术前)和 EVAR 后 12 个月(术后)以及 11 名患者平均 16 个月后(OAR 术后)测量凝血酶原片段(PF)1+2、凝血酶抗凝血酶(TAT)复合物、纤溶酶原激活物抑制剂(PAI)活性和组织型纤溶酶原激活物(t-PA)抗原。
术前,AAA 患者的 PF1+2 水平明显高于 AMC。术后 EVAR 和 OAR 的 PF1+2 水平明显低于术前值,与 AMC 相似。AMC、术前 AAA 和 EVAR 后患者的 TAT、PAI 或 t-PA 之间无显著差异。OAR 术后,PAI 活性明显高于术前患者。
AAA 患者存在凝血酶生成增加而纤溶无上调的促血栓形成状态。EVAR 和 OAR 后,AAA 患者观察到的促血栓形成、低纤溶状态在中期恢复正常,尽管 OAR 后纤溶有下降趋势。